Xtant Medical Holdings (XTNT) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts XTNT Hot Sheet
Join SI Premium – FREE
Xtant Medical Holdings (NYSE: XTNT) reported Q2 EPS of ($0.02), in-line with the analyst estimate of ($0.02). Revenue for the quarter came in at $20.23 million versus the consensus estimate of $18.8 million.
For earnings history and earnings-related data on Xtant Medical Holdings (XTNT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- Nebius soars on second quarter revenue beat
- PolyPid Ltd. (PYPD) Tops Q2 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
